K2M acquired Cardinal Spine’s cervical static corpectomy cage, to be branded as the PALO ALTO® system. The device is reported to be the first static corpectomy cage to receive FDA 510(k) clearance for cervical applications.
PALO ALTO received its clearance in 1Q16, and is intended for use with autograft or allogenic bone graft as an adjunct to fusion. As the C-VBR, it was the second cervical vertebral body replacement device to be cleared by FDA, following NuVasive’s 4Q15 clearance for the X-Core® Mini Cervical Corpectomy System.
K2M acquired Cardinal Spine's cervical static corpectomy cage, to be branded as the PALO ALTO® system. The device is reported to be the first static corpectomy cage to receive FDA 510(k) clearance for cervical applications.
PALO ALTO received its clearance in 1Q16, and is intended for use with autograft or allogenic bone...
K2M acquired Cardinal Spine’s cervical static corpectomy cage, to be branded as the PALO ALTO® system. The device is reported to be the first static corpectomy cage to receive FDA 510(k) clearance for cervical applications.
PALO ALTO received its clearance in 1Q16, and is intended for use with autograft or allogenic bone graft as an adjunct to fusion. As the C-VBR, it was the second cervical vertebral body replacement device to be cleared by FDA, following NuVasive’s 4Q15 clearance for the X-Core® Mini Cervical Corpectomy System.
Copy to clipboard 
